The Goldman Sachs Group Begins Coverage on Kestra Medical Technologies (NASDAQ:KMTS)

The Goldman Sachs Group initiated coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a research note published on Monday, MarketBeat Ratings reports. The brokerage issued a neutral rating and a $24.00 price objective on the stock.

Separately, Stifel Nicolaus began coverage on Kestra Medical Technologies in a research note on Monday. They issued a “buy” rating and a $28.00 target price on the stock. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $27.67.

Kestra Medical Technologies Trading Up 6.4 %

KMTS opened at $24.92 on Monday. Kestra Medical Technologies has a 1 year low of $20.00 and a 1 year high of $25.98.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.